nodes	percent_of_prediction	percent_of_DWPC	metapath
Apomorphine—Parkinson's disease—Bromocriptine—type 2 diabetes mellitus	0.338	1	CpDpCtD
Apomorphine—ADRA2A—type 2 diabetes mellitus	0.108	0.521	CbGaD
Apomorphine—HTR2C—type 2 diabetes mellitus	0.0994	0.479	CbGaD
Apomorphine—DRD5—Bromocriptine—type 2 diabetes mellitus	0.0372	0.123	CbGbCtD
Apomorphine—DRD4—Bromocriptine—type 2 diabetes mellitus	0.0265	0.0874	CbGbCtD
Apomorphine—HTR1D—Bromocriptine—type 2 diabetes mellitus	0.0218	0.0719	CbGbCtD
Apomorphine—HTR2B—Bromocriptine—type 2 diabetes mellitus	0.0214	0.0704	CbGbCtD
Apomorphine—HTR1B—Bromocriptine—type 2 diabetes mellitus	0.0209	0.069	CbGbCtD
Apomorphine—ADRA1D—Bromocriptine—type 2 diabetes mellitus	0.0209	0.069	CbGbCtD
Apomorphine—DRD3—Bromocriptine—type 2 diabetes mellitus	0.0197	0.065	CbGbCtD
Apomorphine—ADRA2C—Bromocriptine—type 2 diabetes mellitus	0.019	0.0626	CbGbCtD
Apomorphine—DRD1—Bromocriptine—type 2 diabetes mellitus	0.019	0.0626	CbGbCtD
Apomorphine—ADRA2B—Bromocriptine—type 2 diabetes mellitus	0.018	0.0594	CbGbCtD
Apomorphine—ADRA1B—Bromocriptine—type 2 diabetes mellitus	0.0152	0.0502	CbGbCtD
Apomorphine—HTR2C—Bromocriptine—type 2 diabetes mellitus	0.0139	0.0458	CbGbCtD
Apomorphine—HTR1A—Bromocriptine—type 2 diabetes mellitus	0.0131	0.0432	CbGbCtD
Apomorphine—HTR2A—Bromocriptine—type 2 diabetes mellitus	0.0125	0.0413	CbGbCtD
Apomorphine—ADRA2A—Bromocriptine—type 2 diabetes mellitus	0.0125	0.0413	CbGbCtD
Apomorphine—DRD2—Bromocriptine—type 2 diabetes mellitus	0.0116	0.0381	CbGbCtD
Apomorphine—HTR2A—arteriole—type 2 diabetes mellitus	0.00154	0.106	CbGeAlD
Apomorphine—CALY—islet of Langerhans—type 2 diabetes mellitus	0.00119	0.0817	CbGeAlD
Apomorphine—HTR2A—sympathetic nervous system—type 2 diabetes mellitus	0.000982	0.0672	CbGeAlD
Apomorphine—DRD1—nerve—type 2 diabetes mellitus	0.000953	0.0653	CbGeAlD
Apomorphine—HTR1B—artery—type 2 diabetes mellitus	0.000778	0.0533	CbGeAlD
Apomorphine—HTR1D—artery—type 2 diabetes mellitus	0.000753	0.0516	CbGeAlD
Apomorphine—HTR2A—autonomic nervous system—type 2 diabetes mellitus	0.00066	0.0452	CbGeAlD
Apomorphine—HTR2A—hindlimb—type 2 diabetes mellitus	0.00061	0.0418	CbGeAlD
Apomorphine—DRD2—nerve—type 2 diabetes mellitus	0.000563	0.0386	CbGeAlD
Apomorphine—ADRA2A—peripheral nervous system—type 2 diabetes mellitus	0.00056	0.0384	CbGeAlD
Apomorphine—HTR2A—peripheral nervous system—type 2 diabetes mellitus	0.000476	0.0326	CbGeAlD
Apomorphine—HTR2A—artery—type 2 diabetes mellitus	0.000374	0.0256	CbGeAlD
Apomorphine—HTR2A—nerve—type 2 diabetes mellitus	0.000371	0.0254	CbGeAlD
Apomorphine—ADRA1B—kidney—type 2 diabetes mellitus	0.00035	0.024	CbGeAlD
Apomorphine—HTR2A—endothelium—type 2 diabetes mellitus	0.000316	0.0217	CbGeAlD
Apomorphine—HTR1B—cardiovascular system—type 2 diabetes mellitus	0.00027	0.0185	CbGeAlD
Apomorphine—HTR1D—cardiovascular system—type 2 diabetes mellitus	0.000262	0.0179	CbGeAlD
Apomorphine—HTR1D—kidney—type 2 diabetes mellitus	0.000256	0.0175	CbGeAlD
Apomorphine—HTR2B—cardiovascular system—type 2 diabetes mellitus	0.000244	0.0167	CbGeAlD
Apomorphine—DRD2—retina—type 2 diabetes mellitus	0.000233	0.016	CbGeAlD
Apomorphine—HTR2B—cortex of kidney—type 2 diabetes mellitus	0.000232	0.0159	CbGeAlD
Apomorphine—HTR1A—cardiovascular system—type 2 diabetes mellitus	0.000218	0.0149	CbGeAlD
Apomorphine—HTR2B—adipose tissue—type 2 diabetes mellitus	0.000215	0.0147	CbGeAlD
Apomorphine—ADRA2C—nephron tubule—type 2 diabetes mellitus	0.000213	0.0146	CbGeAlD
Apomorphine—ADRA2A—islet of Langerhans—type 2 diabetes mellitus	0.000211	0.0145	CbGeAlD
Apomorphine—ADRA2C—kidney—type 2 diabetes mellitus	0.000188	0.0128	CbGeAlD
Apomorphine—ADRA2C—pancreas—type 2 diabetes mellitus	0.000186	0.0128	CbGeAlD
Apomorphine—ADRA2C—cortex of kidney—type 2 diabetes mellitus	0.000183	0.0125	CbGeAlD
Apomorphine—ADRA2C—adipose tissue—type 2 diabetes mellitus	0.000169	0.0116	CbGeAlD
Apomorphine—Nausea—Acarbose—type 2 diabetes mellitus	0.000164	0.00219	CcSEcCtD
Apomorphine—Constipation—Glipizide—type 2 diabetes mellitus	0.000163	0.00218	CcSEcCtD
Apomorphine—Pruritus—Repaglinide—type 2 diabetes mellitus	0.000163	0.00218	CcSEcCtD
Apomorphine—Dyspnoea—Pioglitazone—type 2 diabetes mellitus	0.000163	0.00218	CcSEcCtD
Apomorphine—Mental disorder—Gliclazide—type 2 diabetes mellitus	0.000163	0.00217	CcSEcCtD
Apomorphine—Confusional state—Bromocriptine—type 2 diabetes mellitus	0.000162	0.00216	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Sitagliptin—type 2 diabetes mellitus	0.000162	0.00216	CcSEcCtD
Apomorphine—Insomnia—Glimepiride—type 2 diabetes mellitus	0.000161	0.00215	CcSEcCtD
Apomorphine—Oedema—Bromocriptine—type 2 diabetes mellitus	0.000161	0.00215	CcSEcCtD
Apomorphine—Insomnia—Sitagliptin—type 2 diabetes mellitus	0.000161	0.00214	CcSEcCtD
Apomorphine—Dyspnoea—Glimepiride—type 2 diabetes mellitus	0.000159	0.00212	CcSEcCtD
Apomorphine—Urinary tract infection—Irbesartan—type 2 diabetes mellitus	0.000159	0.00212	CcSEcCtD
Apomorphine—Somnolence—Glimepiride—type 2 diabetes mellitus	0.000159	0.00211	CcSEcCtD
Apomorphine—Nausea—Nateglinide—type 2 diabetes mellitus	0.000158	0.00211	CcSEcCtD
Apomorphine—Shock—Bromocriptine—type 2 diabetes mellitus	0.000158	0.00211	CcSEcCtD
Apomorphine—Somnolence—Sitagliptin—type 2 diabetes mellitus	0.000158	0.00211	CcSEcCtD
Apomorphine—Diarrhoea—Repaglinide—type 2 diabetes mellitus	0.000158	0.00211	CcSEcCtD
Apomorphine—Fatigue—Pioglitazone—type 2 diabetes mellitus	0.000158	0.00211	CcSEcCtD
Apomorphine—Feeling abnormal—Glipizide—type 2 diabetes mellitus	0.000157	0.0021	CcSEcCtD
Apomorphine—Asthenia—Rosiglitazone—type 2 diabetes mellitus	0.000157	0.00209	CcSEcCtD
Apomorphine—Back pain—Gliclazide—type 2 diabetes mellitus	0.000156	0.00209	CcSEcCtD
Apomorphine—Orthostatic hypotension—Ramipril—type 2 diabetes mellitus	0.000156	0.00209	CcSEcCtD
Apomorphine—Pneumonia—Losartan—type 2 diabetes mellitus	0.000155	0.00206	CcSEcCtD
Apomorphine—Pruritus—Rosiglitazone—type 2 diabetes mellitus	0.000154	0.00206	CcSEcCtD
Apomorphine—HTR2A—retina—type 2 diabetes mellitus	0.000154	0.0105	CbGeAlD
Apomorphine—Fatigue—Glimepiride—type 2 diabetes mellitus	0.000154	0.00205	CcSEcCtD
Apomorphine—Arthralgia—Glyburide—type 2 diabetes mellitus	0.000153	0.00205	CcSEcCtD
Apomorphine—Fatigue—Sitagliptin—type 2 diabetes mellitus	0.000153	0.00204	CcSEcCtD
Apomorphine—Constipation—Sitagliptin—type 2 diabetes mellitus	0.000152	0.00203	CcSEcCtD
Apomorphine—Feeling abnormal—Pioglitazone—type 2 diabetes mellitus	0.000151	0.00201	CcSEcCtD
Apomorphine—Hypotension—Bromocriptine—type 2 diabetes mellitus	0.00015	0.00201	CcSEcCtD
Apomorphine—Mental disorder—Valsartan—type 2 diabetes mellitus	0.00015	0.002	CcSEcCtD
Apomorphine—Urinary tract infection—Losartan—type 2 diabetes mellitus	0.00015	0.00199	CcSEcCtD
Apomorphine—Diarrhoea—Rosiglitazone—type 2 diabetes mellitus	0.000149	0.00199	CcSEcCtD
Apomorphine—ADRA2A—pancreas—type 2 diabetes mellitus	0.000149	0.0102	CbGeAlD
Apomorphine—Confusional state—Glyburide—type 2 diabetes mellitus	0.000148	0.00198	CcSEcCtD
Apomorphine—Mental disorder—Orlistat—type 2 diabetes mellitus	0.000148	0.00197	CcSEcCtD
Apomorphine—Oedema—Glyburide—type 2 diabetes mellitus	0.000147	0.00196	CcSEcCtD
Apomorphine—Feeling abnormal—Glimepiride—type 2 diabetes mellitus	0.000147	0.00196	CcSEcCtD
Apomorphine—Vomiting—Repaglinide—type 2 diabetes mellitus	0.000147	0.00196	CcSEcCtD
Apomorphine—Feeling abnormal—Sitagliptin—type 2 diabetes mellitus	0.000146	0.00195	CcSEcCtD
Apomorphine—ADRA2A—cortex of kidney—type 2 diabetes mellitus	0.000146	0.00998	CbGeAlD
Apomorphine—Insomnia—Bromocriptine—type 2 diabetes mellitus	0.000145	0.00194	CcSEcCtD
Apomorphine—Headache—Repaglinide—type 2 diabetes mellitus	0.000145	0.00193	CcSEcCtD
Apomorphine—Shock—Glyburide—type 2 diabetes mellitus	0.000145	0.00193	CcSEcCtD
Apomorphine—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.000144	0.00193	CcSEcCtD
Apomorphine—Flushing—Metformin—type 2 diabetes mellitus	0.000144	0.00193	CcSEcCtD
Apomorphine—Sweating increased—Ramipril—type 2 diabetes mellitus	0.000144	0.00192	CcSEcCtD
Apomorphine—Angina pectoris—Ramipril—type 2 diabetes mellitus	0.000144	0.00192	CcSEcCtD
Apomorphine—Back pain—Valsartan—type 2 diabetes mellitus	0.000144	0.00192	CcSEcCtD
Apomorphine—Dyspnoea—Bromocriptine—type 2 diabetes mellitus	0.000143	0.00191	CcSEcCtD
Apomorphine—Somnolence—Bromocriptine—type 2 diabetes mellitus	0.000143	0.00191	CcSEcCtD
Apomorphine—Loss of consciousness—Gliclazide—type 2 diabetes mellitus	0.000142	0.0019	CcSEcCtD
Apomorphine—Hyperhidrosis—Glyburide—type 2 diabetes mellitus	0.000142	0.0019	CcSEcCtD
Apomorphine—Back pain—Orlistat—type 2 diabetes mellitus	0.000142	0.0019	CcSEcCtD
Apomorphine—Fatigue—Bromocriptine—type 2 diabetes mellitus	0.000139	0.00185	CcSEcCtD
Apomorphine—Chest pain—Gliclazide—type 2 diabetes mellitus	0.000138	0.00184	CcSEcCtD
Apomorphine—Arthralgia—Gliclazide—type 2 diabetes mellitus	0.000138	0.00184	CcSEcCtD
Apomorphine—Constipation—Bromocriptine—type 2 diabetes mellitus	0.000138	0.00184	CcSEcCtD
Apomorphine—Hypotension—Glyburide—type 2 diabetes mellitus	0.000137	0.00183	CcSEcCtD
Apomorphine—Anxiety—Gliclazide—type 2 diabetes mellitus	0.000137	0.00183	CcSEcCtD
Apomorphine—Nausea—Repaglinide—type 2 diabetes mellitus	0.000137	0.00183	CcSEcCtD
Apomorphine—Asthenia—Glipizide—type 2 diabetes mellitus	0.000137	0.00183	CcSEcCtD
Apomorphine—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000137	0.00182	CcSEcCtD
Apomorphine—Flushing—Irbesartan—type 2 diabetes mellitus	0.000136	0.00182	CcSEcCtD
Apomorphine—Pruritus—Glipizide—type 2 diabetes mellitus	0.000135	0.0018	CcSEcCtD
Apomorphine—ADRA2A—adipose tissue—type 2 diabetes mellitus	0.000135	0.00924	CbGeAlD
Apomorphine—Musculoskeletal discomfort—Glyburide—type 2 diabetes mellitus	0.000134	0.00179	CcSEcCtD
Apomorphine—Syncope—Valsartan—type 2 diabetes mellitus	0.000133	0.00178	CcSEcCtD
Apomorphine—Confusional state—Gliclazide—type 2 diabetes mellitus	0.000133	0.00178	CcSEcCtD
Apomorphine—Feeling abnormal—Bromocriptine—type 2 diabetes mellitus	0.000133	0.00177	CcSEcCtD
Apomorphine—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.000131	0.00175	CcSEcCtD
Apomorphine—Dyspnoea—Glyburide—type 2 diabetes mellitus	0.000131	0.00175	CcSEcCtD
Apomorphine—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000131	0.00174	CcSEcCtD
Apomorphine—Loss of consciousness—Valsartan—type 2 diabetes mellitus	0.000131	0.00174	CcSEcCtD
Apomorphine—HTR2A—cardiovascular system—type 2 diabetes mellitus	0.00013	0.00891	CbGeAlD
Apomorphine—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.00013	0.00173	CcSEcCtD
Apomorphine—Urinary tract infection—Ramipril—type 2 diabetes mellitus	0.000128	0.00171	CcSEcCtD
Apomorphine—Flushing—Losartan—type 2 diabetes mellitus	0.000128	0.00171	CcSEcCtD
Apomorphine—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000128	0.00171	CcSEcCtD
Apomorphine—Hyperhidrosis—Gliclazide—type 2 diabetes mellitus	0.000128	0.0017	CcSEcCtD
Apomorphine—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000128	0.0017	CcSEcCtD
Apomorphine—HTR2A—kidney—type 2 diabetes mellitus	0.000127	0.00872	CbGeAlD
Apomorphine—Chest pain—Valsartan—type 2 diabetes mellitus	0.000127	0.00169	CcSEcCtD
Apomorphine—Arthralgia—Valsartan—type 2 diabetes mellitus	0.000127	0.00169	CcSEcCtD
Apomorphine—Dizziness—Glipizide—type 2 diabetes mellitus	0.000126	0.00169	CcSEcCtD
Apomorphine—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000126	0.00168	CcSEcCtD
Apomorphine—Anxiety—Valsartan—type 2 diabetes mellitus	0.000126	0.00168	CcSEcCtD
Apomorphine—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000125	0.00167	CcSEcCtD
Apomorphine—Chest pain—Orlistat—type 2 diabetes mellitus	0.000125	0.00167	CcSEcCtD
Apomorphine—Anxiety—Orlistat—type 2 diabetes mellitus	0.000125	0.00166	CcSEcCtD
Apomorphine—Hypotension—Gliclazide—type 2 diabetes mellitus	0.000123	0.00165	CcSEcCtD
Apomorphine—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000122	0.00163	CcSEcCtD
Apomorphine—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000122	0.00162	CcSEcCtD
Apomorphine—Vomiting—Glipizide—type 2 diabetes mellitus	0.000121	0.00162	CcSEcCtD
Apomorphine—Syncope—Metformin—type 2 diabetes mellitus	0.000121	0.00162	CcSEcCtD
Apomorphine—Oedema—Valsartan—type 2 diabetes mellitus	0.000121	0.00162	CcSEcCtD
Apomorphine—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.000121	0.00162	CcSEcCtD
Apomorphine—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000121	0.00161	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	0.00012	0.0016	CcSEcCtD
Apomorphine—Oedema—Orlistat—type 2 diabetes mellitus	0.00012	0.0016	CcSEcCtD
Apomorphine—Headache—Glipizide—type 2 diabetes mellitus	0.00012	0.0016	CcSEcCtD
Apomorphine—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000119	0.00159	CcSEcCtD
Apomorphine—Shock—Valsartan—type 2 diabetes mellitus	0.000119	0.00159	CcSEcCtD
Apomorphine—Loss of consciousness—Metformin—type 2 diabetes mellitus	0.000119	0.00159	CcSEcCtD
Apomorphine—ADRA2C—liver—type 2 diabetes mellitus	0.000119	0.00812	CbGeAlD
Apomorphine—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000118	0.00157	CcSEcCtD
Apomorphine—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000118	0.00157	CcSEcCtD
Apomorphine—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000118	0.00157	CcSEcCtD
Apomorphine—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000117	0.00157	CcSEcCtD
Apomorphine—Back pain—Losartan—type 2 diabetes mellitus	0.000116	0.00155	CcSEcCtD
Apomorphine—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.000116	0.00155	CcSEcCtD
Apomorphine—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000115	0.00154	CcSEcCtD
Apomorphine—Chest pain—Metformin—type 2 diabetes mellitus	0.000115	0.00154	CcSEcCtD
Apomorphine—Headache—Pioglitazone—type 2 diabetes mellitus	0.000115	0.00153	CcSEcCtD
Apomorphine—Syncope—Irbesartan—type 2 diabetes mellitus	0.000115	0.00153	CcSEcCtD
Apomorphine—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000114	0.00152	CcSEcCtD
Apomorphine—Nausea—Glipizide—type 2 diabetes mellitus	0.000113	0.00151	CcSEcCtD
Apomorphine—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000113	0.00151	CcSEcCtD
Apomorphine—Hypotension—Valsartan—type 2 diabetes mellitus	0.000113	0.00151	CcSEcCtD
Apomorphine—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000113	0.00151	CcSEcCtD
Apomorphine—Constipation—Gliclazide—type 2 diabetes mellitus	0.000113	0.00151	CcSEcCtD
Apomorphine—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.000112	0.0015	CcSEcCtD
Apomorphine—Headache—Glimepiride—type 2 diabetes mellitus	0.000112	0.00149	CcSEcCtD
Apomorphine—Headache—Sitagliptin—type 2 diabetes mellitus	0.000111	0.00149	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000111	0.00147	CcSEcCtD
Apomorphine—Oedema—Metformin—type 2 diabetes mellitus	0.00011	0.00147	CcSEcCtD
Apomorphine—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.00011	0.00147	CcSEcCtD
Apomorphine—Flushing—Ramipril—type 2 diabetes mellitus	0.00011	0.00147	CcSEcCtD
Apomorphine—Insomnia—Valsartan—type 2 diabetes mellitus	0.00011	0.00146	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000109	0.00146	CcSEcCtD
Apomorphine—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000109	0.00145	CcSEcCtD
Apomorphine—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000109	0.00145	CcSEcCtD
Apomorphine—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.000109	0.00145	CcSEcCtD
Apomorphine—Shock—Metformin—type 2 diabetes mellitus	0.000109	0.00145	CcSEcCtD
Apomorphine—Insomnia—Orlistat—type 2 diabetes mellitus	0.000108	0.00145	CcSEcCtD
Apomorphine—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000108	0.00145	CcSEcCtD
Apomorphine—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000108	0.00144	CcSEcCtD
Apomorphine—Somnolence—Valsartan—type 2 diabetes mellitus	0.000108	0.00144	CcSEcCtD
Apomorphine—Syncope—Losartan—type 2 diabetes mellitus	0.000108	0.00144	CcSEcCtD
Apomorphine—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000107	0.00142	CcSEcCtD
Apomorphine—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000106	0.00142	CcSEcCtD
Apomorphine—Nausea—Glimepiride—type 2 diabetes mellitus	0.000106	0.00141	CcSEcCtD
Apomorphine—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.000106	0.00141	CcSEcCtD
Apomorphine—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000106	0.00141	CcSEcCtD
Apomorphine—Asthenia—Glyburide—type 2 diabetes mellitus	0.000105	0.00141	CcSEcCtD
Apomorphine—Fatigue—Valsartan—type 2 diabetes mellitus	0.000105	0.0014	CcSEcCtD
Apomorphine—Oedema—Irbesartan—type 2 diabetes mellitus	0.000104	0.00139	CcSEcCtD
Apomorphine—Pruritus—Glyburide—type 2 diabetes mellitus	0.000104	0.00139	CcSEcCtD
Apomorphine—Mental disorder—Ramipril—type 2 diabetes mellitus	0.000104	0.00138	CcSEcCtD
Apomorphine—Constipation—Valsartan—type 2 diabetes mellitus	0.000104	0.00138	CcSEcCtD
Apomorphine—Fatigue—Orlistat—type 2 diabetes mellitus	0.000103	0.00138	CcSEcCtD
Apomorphine—Hypotension—Metformin—type 2 diabetes mellitus	0.000103	0.00138	CcSEcCtD
Apomorphine—Shock—Irbesartan—type 2 diabetes mellitus	0.000103	0.00137	CcSEcCtD
Apomorphine—Chest pain—Losartan—type 2 diabetes mellitus	0.000102	0.00137	CcSEcCtD
Apomorphine—Arthralgia—Losartan—type 2 diabetes mellitus	0.000102	0.00137	CcSEcCtD
Apomorphine—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000102	0.00136	CcSEcCtD
Apomorphine—Anxiety—Losartan—type 2 diabetes mellitus	0.000102	0.00136	CcSEcCtD
Apomorphine—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000101	0.00134	CcSEcCtD
Apomorphine—Headache—Bromocriptine—type 2 diabetes mellitus	0.000101	0.00134	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000101	0.00134	CcSEcCtD
Apomorphine—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000101	0.00134	CcSEcCtD
Apomorphine—Confusional state—Losartan—type 2 diabetes mellitus	9.89e-05	0.00132	CcSEcCtD
Apomorphine—Feeling abnormal—Orlistat—type 2 diabetes mellitus	9.88e-05	0.00132	CcSEcCtD
Apomorphine—Dyspnoea—Metformin—type 2 diabetes mellitus	9.85e-05	0.00131	CcSEcCtD
Apomorphine—Somnolence—Metformin—type 2 diabetes mellitus	9.82e-05	0.00131	CcSEcCtD
Apomorphine—Oedema—Losartan—type 2 diabetes mellitus	9.81e-05	0.00131	CcSEcCtD
Apomorphine—Hypotension—Irbesartan—type 2 diabetes mellitus	9.74e-05	0.0013	CcSEcCtD
Apomorphine—Shock—Losartan—type 2 diabetes mellitus	9.65e-05	0.00129	CcSEcCtD
Apomorphine—Nausea—Bromocriptine—type 2 diabetes mellitus	9.55e-05	0.00127	CcSEcCtD
Apomorphine—Fatigue—Metformin—type 2 diabetes mellitus	9.52e-05	0.00127	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	9.5e-05	0.00127	CcSEcCtD
Apomorphine—Hyperhidrosis—Losartan—type 2 diabetes mellitus	9.48e-05	0.00127	CcSEcCtD
Apomorphine—Asthenia—Gliclazide—type 2 diabetes mellitus	9.47e-05	0.00126	CcSEcCtD
Apomorphine—Constipation—Metformin—type 2 diabetes mellitus	9.45e-05	0.00126	CcSEcCtD
Apomorphine—Vomiting—Glyburide—type 2 diabetes mellitus	9.35e-05	0.00125	CcSEcCtD
Apomorphine—Pruritus—Gliclazide—type 2 diabetes mellitus	9.34e-05	0.00125	CcSEcCtD
Apomorphine—Dyspnoea—Irbesartan—type 2 diabetes mellitus	9.29e-05	0.00124	CcSEcCtD
Apomorphine—Somnolence—Irbesartan—type 2 diabetes mellitus	9.27e-05	0.00124	CcSEcCtD
Apomorphine—Syncope—Ramipril—type 2 diabetes mellitus	9.24e-05	0.00123	CcSEcCtD
Apomorphine—Headache—Glyburide—type 2 diabetes mellitus	9.21e-05	0.00123	CcSEcCtD
Apomorphine—Hypotension—Losartan—type 2 diabetes mellitus	9.17e-05	0.00122	CcSEcCtD
Apomorphine—Feeling abnormal—Metformin—type 2 diabetes mellitus	9.1e-05	0.00121	CcSEcCtD
Apomorphine—Loss of consciousness—Ramipril—type 2 diabetes mellitus	9.06e-05	0.00121	CcSEcCtD
Apomorphine—Diarrhoea—Gliclazide—type 2 diabetes mellitus	9.03e-05	0.00121	CcSEcCtD
Apomorphine—Fatigue—Irbesartan—type 2 diabetes mellitus	8.99e-05	0.0012	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	8.94e-05	0.00119	CcSEcCtD
Apomorphine—Constipation—Irbesartan—type 2 diabetes mellitus	8.91e-05	0.00119	CcSEcCtD
Apomorphine—Insomnia—Losartan—type 2 diabetes mellitus	8.87e-05	0.00118	CcSEcCtD
Apomorphine—Arthralgia—Ramipril—type 2 diabetes mellitus	8.78e-05	0.00117	CcSEcCtD
Apomorphine—Chest pain—Ramipril—type 2 diabetes mellitus	8.78e-05	0.00117	CcSEcCtD
Apomorphine—Dyspnoea—Losartan—type 2 diabetes mellitus	8.75e-05	0.00117	CcSEcCtD
Apomorphine—Anxiety—Ramipril—type 2 diabetes mellitus	8.74e-05	0.00117	CcSEcCtD
Apomorphine—Nausea—Glyburide—type 2 diabetes mellitus	8.73e-05	0.00117	CcSEcCtD
Apomorphine—Dizziness—Gliclazide—type 2 diabetes mellitus	8.73e-05	0.00116	CcSEcCtD
Apomorphine—Somnolence—Losartan—type 2 diabetes mellitus	8.72e-05	0.00116	CcSEcCtD
Apomorphine—Asthenia—Valsartan—type 2 diabetes mellitus	8.7e-05	0.00116	CcSEcCtD
Apomorphine—Asthenia—Orlistat—type 2 diabetes mellitus	8.6e-05	0.00115	CcSEcCtD
Apomorphine—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	8.59e-05	0.00115	CcSEcCtD
Apomorphine—Pruritus—Valsartan—type 2 diabetes mellitus	8.58e-05	0.00115	CcSEcCtD
Apomorphine—Confusional state—Ramipril—type 2 diabetes mellitus	8.48e-05	0.00113	CcSEcCtD
Apomorphine—Pruritus—Orlistat—type 2 diabetes mellitus	8.48e-05	0.00113	CcSEcCtD
Apomorphine—Fatigue—Losartan—type 2 diabetes mellitus	8.46e-05	0.00113	CcSEcCtD
Apomorphine—Oedema—Ramipril—type 2 diabetes mellitus	8.41e-05	0.00112	CcSEcCtD
Apomorphine—Vomiting—Gliclazide—type 2 diabetes mellitus	8.39e-05	0.00112	CcSEcCtD
Apomorphine—Constipation—Losartan—type 2 diabetes mellitus	8.39e-05	0.00112	CcSEcCtD
Apomorphine—Diarrhoea—Valsartan—type 2 diabetes mellitus	8.3e-05	0.00111	CcSEcCtD
Apomorphine—Shock—Ramipril—type 2 diabetes mellitus	8.28e-05	0.0011	CcSEcCtD
Apomorphine—Headache—Gliclazide—type 2 diabetes mellitus	8.27e-05	0.0011	CcSEcCtD
Apomorphine—Diarrhoea—Orlistat—type 2 diabetes mellitus	8.2e-05	0.00109	CcSEcCtD
Apomorphine—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	8.13e-05	0.00109	CcSEcCtD
Apomorphine—Feeling abnormal—Losartan—type 2 diabetes mellitus	8.08e-05	0.00108	CcSEcCtD
Apomorphine—HTR2A—liver—type 2 diabetes mellitus	8.04e-05	0.00551	CbGeAlD
Apomorphine—Dizziness—Valsartan—type 2 diabetes mellitus	8.02e-05	0.00107	CcSEcCtD
Apomorphine—Dizziness—Orlistat—type 2 diabetes mellitus	7.93e-05	0.00106	CcSEcCtD
Apomorphine—Asthenia—Metformin—type 2 diabetes mellitus	7.93e-05	0.00106	CcSEcCtD
Apomorphine—Hypotension—Ramipril—type 2 diabetes mellitus	7.86e-05	0.00105	CcSEcCtD
Apomorphine—Nausea—Gliclazide—type 2 diabetes mellitus	7.84e-05	0.00105	CcSEcCtD
Apomorphine—Pruritus—Metformin—type 2 diabetes mellitus	7.82e-05	0.00104	CcSEcCtD
Apomorphine—Vomiting—Valsartan—type 2 diabetes mellitus	7.71e-05	0.00103	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	7.66e-05	0.00102	CcSEcCtD
Apomorphine—Vomiting—Orlistat—type 2 diabetes mellitus	7.62e-05	0.00102	CcSEcCtD
Apomorphine—Insomnia—Ramipril—type 2 diabetes mellitus	7.61e-05	0.00102	CcSEcCtD
Apomorphine—Headache—Valsartan—type 2 diabetes mellitus	7.6e-05	0.00101	CcSEcCtD
Apomorphine—Diarrhoea—Metformin—type 2 diabetes mellitus	7.56e-05	0.00101	CcSEcCtD
Apomorphine—Headache—Orlistat—type 2 diabetes mellitus	7.51e-05	0.001	CcSEcCtD
Apomorphine—Dyspnoea—Ramipril—type 2 diabetes mellitus	7.5e-05	0.001	CcSEcCtD
Apomorphine—Asthenia—Irbesartan—type 2 diabetes mellitus	7.48e-05	0.000998	CcSEcCtD
Apomorphine—Somnolence—Ramipril—type 2 diabetes mellitus	7.48e-05	0.000998	CcSEcCtD
Apomorphine—Pruritus—Irbesartan—type 2 diabetes mellitus	7.38e-05	0.000984	CcSEcCtD
Apomorphine—Dizziness—Metformin—type 2 diabetes mellitus	7.3e-05	0.000975	CcSEcCtD
Apomorphine—Fatigue—Ramipril—type 2 diabetes mellitus	7.25e-05	0.000968	CcSEcCtD
Apomorphine—Nausea—Valsartan—type 2 diabetes mellitus	7.21e-05	0.000961	CcSEcCtD
Apomorphine—Constipation—Ramipril—type 2 diabetes mellitus	7.19e-05	0.00096	CcSEcCtD
Apomorphine—Diarrhoea—Irbesartan—type 2 diabetes mellitus	7.13e-05	0.000952	CcSEcCtD
Apomorphine—Nausea—Orlistat—type 2 diabetes mellitus	7.12e-05	0.00095	CcSEcCtD
Apomorphine—Asthenia—Losartan—type 2 diabetes mellitus	7.04e-05	0.000939	CcSEcCtD
Apomorphine—Vomiting—Metformin—type 2 diabetes mellitus	7.02e-05	0.000937	CcSEcCtD
Apomorphine—Pruritus—Losartan—type 2 diabetes mellitus	6.94e-05	0.000926	CcSEcCtD
Apomorphine—Feeling abnormal—Ramipril—type 2 diabetes mellitus	6.93e-05	0.000925	CcSEcCtD
Apomorphine—Headache—Metformin—type 2 diabetes mellitus	6.92e-05	0.000923	CcSEcCtD
Apomorphine—Dizziness—Irbesartan—type 2 diabetes mellitus	6.89e-05	0.00092	CcSEcCtD
Apomorphine—Diarrhoea—Losartan—type 2 diabetes mellitus	6.71e-05	0.000896	CcSEcCtD
Apomorphine—Vomiting—Irbesartan—type 2 diabetes mellitus	6.63e-05	0.000884	CcSEcCtD
Apomorphine—Nausea—Metformin—type 2 diabetes mellitus	6.56e-05	0.000875	CcSEcCtD
Apomorphine—Headache—Irbesartan—type 2 diabetes mellitus	6.53e-05	0.000871	CcSEcCtD
Apomorphine—Dizziness—Losartan—type 2 diabetes mellitus	6.49e-05	0.000866	CcSEcCtD
Apomorphine—Vomiting—Losartan—type 2 diabetes mellitus	6.24e-05	0.000832	CcSEcCtD
Apomorphine—Nausea—Irbesartan—type 2 diabetes mellitus	6.19e-05	0.000826	CcSEcCtD
Apomorphine—Headache—Losartan—type 2 diabetes mellitus	6.15e-05	0.00082	CcSEcCtD
Apomorphine—Asthenia—Ramipril—type 2 diabetes mellitus	6.04e-05	0.000805	CcSEcCtD
Apomorphine—Pruritus—Ramipril—type 2 diabetes mellitus	5.95e-05	0.000794	CcSEcCtD
Apomorphine—Nausea—Losartan—type 2 diabetes mellitus	5.83e-05	0.000778	CcSEcCtD
Apomorphine—Diarrhoea—Ramipril—type 2 diabetes mellitus	5.76e-05	0.000768	CcSEcCtD
Apomorphine—Dizziness—Ramipril—type 2 diabetes mellitus	5.56e-05	0.000742	CcSEcCtD
Apomorphine—Vomiting—Ramipril—type 2 diabetes mellitus	5.35e-05	0.000714	CcSEcCtD
Apomorphine—Headache—Ramipril—type 2 diabetes mellitus	5.27e-05	0.000703	CcSEcCtD
Apomorphine—Nausea—Ramipril—type 2 diabetes mellitus	5e-05	0.000667	CcSEcCtD
Apomorphine—ADRA2C—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.57e-06	2.56e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.57e-06	2.56e-05	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—RELA—type 2 diabetes mellitus	1.56e-06	2.55e-05	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—RELA—type 2 diabetes mellitus	1.56e-06	2.55e-05	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.56e-06	2.54e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—HIF1A—type 2 diabetes mellitus	1.55e-06	2.53e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—IRS2—type 2 diabetes mellitus	1.55e-06	2.53e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Metabolism—INS—type 2 diabetes mellitus	1.55e-06	2.53e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—AGT—type 2 diabetes mellitus	1.55e-06	2.53e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.55e-06	2.52e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.54e-06	2.52e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.54e-06	2.52e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Hemostasis—AKT1—type 2 diabetes mellitus	1.54e-06	2.51e-05	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.54e-06	2.51e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.54e-06	2.5e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Metabolism—PTGS2—type 2 diabetes mellitus	1.53e-06	2.5e-05	CbGpPWpGaD
Apomorphine—HTR2B—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.53e-06	2.49e-05	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.52e-06	2.48e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—CALM1—type 2 diabetes mellitus	1.52e-06	2.48e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.52e-06	2.48e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.52e-06	2.48e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—LEP—type 2 diabetes mellitus	1.52e-06	2.47e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—APOE—type 2 diabetes mellitus	1.52e-06	2.47e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.52e-06	2.47e-05	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.51e-06	2.47e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.51e-06	2.47e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.51e-06	2.47e-05	CbGpPWpGaD
Apomorphine—HTR1D—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.51e-06	2.46e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.51e-06	2.46e-05	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.51e-06	2.46e-05	CbGpPWpGaD
Apomorphine—HTR2B—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.5e-06	2.45e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—APOA1—type 2 diabetes mellitus	1.5e-06	2.45e-05	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.5e-06	2.44e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.5e-06	2.44e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.5e-06	2.44e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.49e-06	2.43e-05	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.48e-06	2.42e-05	CbGpPWpGaD
Apomorphine—HTR1B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.48e-06	2.41e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.47e-06	2.39e-05	CbGpPWpGaD
Apomorphine—DRD4—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.45e-06	2.37e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—INS—type 2 diabetes mellitus	1.45e-06	2.36e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.45e-06	2.36e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.45e-06	2.36e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.44e-06	2.35e-05	CbGpPWpGaD
Apomorphine—DRD1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.44e-06	2.35e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.44e-06	2.35e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.44e-06	2.35e-05	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—SRC—type 2 diabetes mellitus	1.43e-06	2.34e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.43e-06	2.33e-05	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.43e-06	2.33e-05	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.43e-06	2.33e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—INS—type 2 diabetes mellitus	1.43e-06	2.32e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.43e-06	2.32e-05	CbGpPWpGaD
Apomorphine—DRD3—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.42e-06	2.32e-05	CbGpPWpGaD
Apomorphine—ADRA1D—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.42e-06	2.32e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Metabolism—ALB—type 2 diabetes mellitus	1.42e-06	2.32e-05	CbGpPWpGaD
Apomorphine—DRD1—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.42e-06	2.31e-05	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.42e-06	2.31e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—RELA—type 2 diabetes mellitus	1.41e-06	2.3e-05	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.41e-06	2.3e-05	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.41e-06	2.3e-05	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—SRC—type 2 diabetes mellitus	1.4e-06	2.29e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.4e-06	2.29e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.4e-06	2.28e-05	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.4e-06	2.28e-05	CbGpPWpGaD
Apomorphine—DRD3—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.4e-06	2.28e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.4e-06	2.28e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.4e-06	2.28e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.4e-06	2.28e-05	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.4e-06	2.28e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.39e-06	2.27e-05	CbGpPWpGaD
Apomorphine—HTR2B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.39e-06	2.26e-05	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—SRC—type 2 diabetes mellitus	1.38e-06	2.25e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.38e-06	2.25e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.38e-06	2.25e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.38e-06	2.25e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.38e-06	2.25e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.37e-06	2.24e-05	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.37e-06	2.23e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—RELA—type 2 diabetes mellitus	1.36e-06	2.22e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Metabolism—PIK3R1—type 2 diabetes mellitus	1.36e-06	2.22e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Metabolism—NOS3—type 2 diabetes mellitus	1.36e-06	2.22e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—RELA—type 2 diabetes mellitus	1.35e-06	2.21e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.35e-06	2.21e-05	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.35e-06	2.2e-05	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.35e-06	2.19e-05	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.34e-06	2.18e-05	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.33e-06	2.17e-05	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.33e-06	2.17e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.33e-06	2.17e-05	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—SRC—type 2 diabetes mellitus	1.32e-06	2.15e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—RELA—type 2 diabetes mellitus	1.32e-06	2.15e-05	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.32e-06	2.15e-05	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.32e-06	2.15e-05	CbGpPWpGaD
Apomorphine—DRD1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.31e-06	2.13e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.31e-06	2.13e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—RELA—type 2 diabetes mellitus	1.3e-06	2.11e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—INS—type 2 diabetes mellitus	1.3e-06	2.11e-05	CbGpPWpGaD
Apomorphine—DRD3—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.29e-06	2.11e-05	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.29e-06	2.11e-05	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.29e-06	2.1e-05	CbGpPWpGaD
Apomorphine—ADRA2B—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.28e-06	2.09e-05	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.28e-06	2.09e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.28e-06	2.08e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.27e-06	2.07e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.27e-06	2.07e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.27e-06	2.07e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.26e-06	2.06e-05	CbGpPWpGaD
Apomorphine—DRD5—Signaling Pathways—IL6—type 2 diabetes mellitus	1.26e-06	2.06e-05	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.26e-06	2.05e-05	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.26e-06	2.05e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.25e-06	2.04e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.25e-06	2.04e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.25e-06	2.04e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.25e-06	2.04e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.25e-06	2.03e-05	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—SRC—type 2 diabetes mellitus	1.24e-06	2.03e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Metabolism—PTGS2—type 2 diabetes mellitus	1.24e-06	2.03e-05	CbGpPWpGaD
Apomorphine—HTR1A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.24e-06	2.02e-05	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.24e-06	2.01e-05	CbGpPWpGaD
Apomorphine—HTR2C—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.23e-06	2.01e-05	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.23e-06	2.01e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.23e-06	2e-05	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—SRC—type 2 diabetes mellitus	1.23e-06	2e-05	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—SRC—type 2 diabetes mellitus	1.23e-06	2e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.22e-06	1.99e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.22e-06	1.99e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.21e-06	1.98e-05	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.21e-06	1.98e-05	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.21e-06	1.98e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.2e-06	1.96e-05	CbGpPWpGaD
Apomorphine—ADRA2C—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.2e-06	1.96e-05	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.2e-06	1.95e-05	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.2e-06	1.95e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—RELA—type 2 diabetes mellitus	1.2e-06	1.95e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.19e-06	1.94e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.19e-06	1.94e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.19e-06	1.94e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.18e-06	1.92e-05	CbGpPWpGaD
Apomorphine—ADRA1B—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.18e-06	1.92e-05	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.18e-06	1.92e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—RELA—type 2 diabetes mellitus	1.18e-06	1.92e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.17e-06	1.91e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.17e-06	1.9e-05	CbGpPWpGaD
Apomorphine—DRD5—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.16e-06	1.9e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.16e-06	1.89e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.16e-06	1.89e-05	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.16e-06	1.89e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.15e-06	1.88e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.15e-06	1.87e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.14e-06	1.86e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.14e-06	1.85e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.14e-06	1.85e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.13e-06	1.84e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.12e-06	1.83e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.12e-06	1.83e-05	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.11e-06	1.81e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.11e-06	1.81e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—SRC—type 2 diabetes mellitus	1.11e-06	1.81e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.11e-06	1.8e-05	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.1e-06	1.79e-05	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.1e-06	1.79e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.09e-06	1.78e-05	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.09e-06	1.78e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.09e-06	1.78e-05	CbGpPWpGaD
Apomorphine—DRD2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.09e-06	1.77e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.08e-06	1.76e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.08e-06	1.76e-05	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.08e-06	1.75e-05	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.08e-06	1.75e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.07e-06	1.75e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.07e-06	1.75e-05	CbGpPWpGaD
Apomorphine—HTR2A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.07e-06	1.75e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—RELA—type 2 diabetes mellitus	1.07e-06	1.74e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—SRC—type 2 diabetes mellitus	1.07e-06	1.74e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—SRC—type 2 diabetes mellitus	1.06e-06	1.74e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.06e-06	1.73e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.05e-06	1.72e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.04e-06	1.7e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.04e-06	1.69e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—SRC—type 2 diabetes mellitus	1.04e-06	1.69e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—SRC—type 2 diabetes mellitus	1.02e-06	1.66e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.02e-06	1.66e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.01e-06	1.64e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.01e-06	1.64e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—MMP9—type 2 diabetes mellitus	1e-06	1.63e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	9.93e-07	1.62e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	9.92e-07	1.62e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	9.91e-07	1.62e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	9.88e-07	1.61e-05	CbGpPWpGaD
Apomorphine—ADRA2A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	9.74e-07	1.59e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	9.73e-07	1.59e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—EGFR—type 2 diabetes mellitus	9.72e-07	1.58e-05	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—IL6—type 2 diabetes mellitus	9.66e-07	1.58e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—CASP3—type 2 diabetes mellitus	9.65e-07	1.57e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling by GPCR—IL6—type 2 diabetes mellitus	9.59e-07	1.56e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	9.57e-07	1.56e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—TGFB1—type 2 diabetes mellitus	9.52e-07	1.55e-05	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—IL6—type 2 diabetes mellitus	9.46e-07	1.54e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—SRC—type 2 diabetes mellitus	9.4e-07	1.53e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—EGFR—type 2 diabetes mellitus	9.38e-07	1.53e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—EGFR—type 2 diabetes mellitus	9.33e-07	1.52e-05	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—IL6—type 2 diabetes mellitus	9.31e-07	1.52e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—TGFB1—type 2 diabetes mellitus	9.26e-07	1.51e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—SRC—type 2 diabetes mellitus	9.25e-07	1.51e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	9.15e-07	1.49e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—MMP9—type 2 diabetes mellitus	9.12e-07	1.49e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	9.11e-07	1.49e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—EGFR—type 2 diabetes mellitus	9.08e-07	1.48e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	9.03e-07	1.47e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	9e-07	1.47e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—EGFR—type 2 diabetes mellitus	8.93e-07	1.46e-05	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—AKT1—type 2 diabetes mellitus	8.92e-07	1.45e-05	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—IL6—type 2 diabetes mellitus	8.89e-07	1.45e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	8.85e-07	1.44e-05	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—AKT1—type 2 diabetes mellitus	8.73e-07	1.42e-05	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—AKT1—type 2 diabetes mellitus	8.59e-07	1.4e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—SRC—type 2 diabetes mellitus	8.41e-07	1.37e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	8.4e-07	1.37e-05	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—IL6—type 2 diabetes mellitus	8.38e-07	1.37e-05	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—IL6—type 2 diabetes mellitus	8.27e-07	1.35e-05	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—IL6—type 2 diabetes mellitus	8.27e-07	1.35e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	8.26e-07	1.35e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—EGFR—type 2 diabetes mellitus	8.24e-07	1.34e-05	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—AKT1—type 2 diabetes mellitus	8.2e-07	1.34e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	8.19e-07	1.34e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—EGFR—type 2 diabetes mellitus	8.1e-07	1.32e-05	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.73e-07	1.26e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Metabolism—AKT1—type 2 diabetes mellitus	7.7e-07	1.25e-05	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.63e-07	1.24e-05	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.63e-07	1.24e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	7.52e-07	1.23e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—IL6—type 2 diabetes mellitus	7.47e-07	1.22e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—EGFR—type 2 diabetes mellitus	7.37e-07	1.2e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—IL6—type 2 diabetes mellitus	7.21e-07	1.18e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—IL6—type 2 diabetes mellitus	7.17e-07	1.17e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—IL6—type 2 diabetes mellitus	6.98e-07	1.14e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.89e-07	1.12e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—IL6—type 2 diabetes mellitus	6.87e-07	1.12e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.65e-07	1.08e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.62e-07	1.08e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.44e-07	1.05e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.33e-07	1.03e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—IL6—type 2 diabetes mellitus	6.33e-07	1.03e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Metabolism—AKT1—type 2 diabetes mellitus	6.25e-07	1.02e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—IL6—type 2 diabetes mellitus	6.23e-07	1.02e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.84e-07	9.52e-06	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.75e-07	9.37e-06	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—IL6—type 2 diabetes mellitus	5.67e-07	9.24e-06	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.23e-07	8.52e-06	CbGpPWpGaD
